Erk1 positively regulates osteoclast differentiation and bone resorptive activity

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  He, Yongzheng ^a   Staser, Karl ^a   Rhodes, Steven D ^a   Liu, Yaling ^a   Wu, Xiaohua ^a   Park, Su Jung ^a   Yuan, Jin ^a   Yang, Xianlin ^a   Li, Xiaohong ^a   Jiang, Li ^a   Chen, Shi ^a   Yang, Feng Chun ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; TARTRATE-RESISTANT ACID PHOSPHATASE;

ANIMAL CELL; ARTICLE; BONE DENSITY; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MIGRATION; CONTROLLED STUDY; ERK1 GENE; ERK2 GENE; GENE; GENE DISRUPTION; HOMOZYGOSITY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PROTEIN PHOSPHORYLATION; ANIMAL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL MOTION; CYTOLOGY; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; MOUSE MUTANT; PATHOLOGY; STEM CELL; TRANSGENIC MOUSE; WESTERN BLOTTING;

MUS;

ACID PHOSPHATASE; ANIMALS; BLOTTING, WESTERN; BONE DENSITY; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BONE RESORPTION; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN TYPE I; FEMALE; HUMANS; ISOENZYMES; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOCLASTS; PEPTIDES; STEM CELLS; X-RAY MICROTOMOGRAPHY;

EID: 80053058791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024780     Document Type: Article

References (46)

1. Raisz LG, (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115: 3318-3325.
2. Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS, (2008) The cell biology of bone metabolism. J Clin Pathol 61: 577-587.
3. Chambers TJ, (2000) Regulation of the differentiation and function of osteoclasts. J Pathol 192: 4-13.
4. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
5. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95: 3597-3602.
6. Cohen MM Jr, (2006) The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet A 140: 2646-2706.
7. Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y, (2008) The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat 29: 992-1006.
8. Newbern J, Zhong J, Wickramasinghe RS, Li X, Wu Y, et al. (2008) Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc Natl Acad Sci U S A 105: 17115-17120.
9. Stevenson D, Schwarz E, Carey J, Viskochil D, Hanson H, et al. Bone resorption in syndromes of the Ras/MAPK pathway. Clin Genet.
10. Leevers SJ, Paterson HF, Marshall CJ, (1994) Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369: 411-414.
11. Leevers SJ, Marshall CJ, (1992) Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J 11: 569-574.
12. Shaul YD, Gibor G, Plotnikov A, Seger R, (2009) Specific phosphorylation and activation of ERK1c by MEK1b: a unique route in the ERK cascade. Genes Dev 23: 1779-1790.
13. Paroo Z, Ye X, Chen S, Liu Q, (2009) Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 139: 112-122.
14. Fiil BK, Petersen K, Petersen M, Mundy J, (2009) Gene regulation by MAP kinase cascades. Curr Opin Plant Biol 12: 615-621.
15. Subramaniam S, Unsicker K, (2009) ERK and cell death: ERK1/2 in neuronal death. FEBS J 277: 22-29.
16. Bates ME, Sedgwick JB, Zhu Y, Liu LY, Heuser RG, et al. (2010) Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils. J Immunol 184: 7125-7133.
17. Bourcier C, Jacquel A, Hess J, Peyrottes I, Angel P, et al. (2006) p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis. Cancer Res 66: 2700-2707.
18. Pages G, Guerin S, Grall D, Bonino F, Smith A, et al. (1999) Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286: 1374-1377.
19. Bost F, Aouadi M, Caron L, Even P, Belmonte N, et al. (2005) The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54: 402-411.
20. Matsushita T, Chan YY, Kawanami A, Balmes G, Landreth GE, et al. (2009) Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol Cell Biol 29: 5843-5857.
21. Yasuda T, Sanjo H, Pages G, Kawano Y, Karasuyama H, et al. (2008) Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 28: 499-508.
22. Fischer AM, Katayama CD, Pages G, Pouyssegur J, Hedrick SM, (2005) The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23: 431-443.
23. D'Souza WN, Chang CF, Fischer AM, Li M, Hedrick SM, (2008) The Erk2 MAPK regulates CD8 T cell proliferation and survival. J Immunol 181: 7617-7629.
24. Bradley EW, Oursler MJ, (2008) Osteoclast culture and resorption assays. Methods Mol Biol 455: 19-35.
25. Kim HH, Chung WJ, Lee SW, Chung PJ, You JW, et al. (2003) Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation. Exp Cell Res 289: 368-377.
26. Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J, et al. (2008) Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow. Cell 135: 437-448.
27. Yang FC, Chen S, Robling AG, Yu X, Nebesio TD, et al. (2006) Hyperactivation of p21 and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. J Clin Invest 116: 2880-2891.
28. Munugalavadla V, Vemula S, Sims EC, Krishnan S, Chen S, et al. (2008) The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration. Mol Cell Biol 28: 7182-7198.
29. Yan J, Chen S, Zhang Y, Li X, Li Y, et al. (2008) Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1. Hum Mol Genet 17: 936-948.
30. Aubin JE, (1992) Osteoclast adhesion and resorption: the role of podosomes. J Bone Miner Res 7: 365-368.
31. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, et al. (2000) Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105: 433-440.
32. Chellaiah MA, Hruska KA, (2003) The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int 72: 197-205.
33. Munugalavadla V, Borneo J, Ingram DA, Kapur R, (2005) p85alpha subunit of class IA PI-3 kinase is crucial for macrophage growth and migration. Blood 106: 103-109.
34. Seibel MJ, (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 26: 97-122.
35. Yip KH, Feng H, Pavlos NJ, Zheng MH, Xu J, (2006) p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone. Am J Pathol 169: 503-514.
36. Abbas S, Clohisy JC, Abu-Amer Y, (2003) Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res 21: 1041-1048.
37. Yamanaka Y, Abu-Amer Y, Faccio R, Clohisy JC, (2006) Map kinase c-JUN N-terminal kinase mediates PMMA induction of osteoclasts. J Orthop Res 24: 1349-1357.
38. Wu X, Estwick SA, Chen S, Yu M, Ming W, et al. (2006) Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. Hum Mol Genet 15: 2837-2845.
39. Tumurkhuu M, Saitoh M, Sato A, Takahashi K, Mimaki M, et al. Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/MEK/ERK pathway. Pediatr Int 52: 557-562.
40. Meloche S, Pouyssegur J, (2007) The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26: 3227-3239.
41. Guihard S, Clay D, Cocault L, Saulnier N, Opolon P, et al. The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis. Blood 115: 3686-3694.
42. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, et al. (2006) ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 5: 14.
43. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, et al. (2002) Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34: 807-820.
44. Saba-El-Leil MK, Vella FD, Vernay B, Voisin L, Chen L, et al. (2003) An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep 4: 964-968.
45. Boyle WJ, Simonet WS, Lacey DL, (2003) Osteoclast differentiation and activation. Nature 423: 337-342.
46. Kinoshita T, Yoshida I, Nakae S, Okita K, Gouda M, et al. (2008) Crystal structure of human mono-phosphorylated ERK1 at Tyr204. Biochem Biophys Res Commun 377: 1123-1127.